Loxapine

Loxitane

10MG BASE, 25MG BASE, 50MG BASE … capsuleÉtats-UnisNon commercialiséAutorisé le 25 févr. 1975

Dans d’autres pays

Les mêmes substances actives dans d’autres registres, en commençant par la même marque.

Loxapac IMCanada · 50 MG / ML · Solution · Sandoz Canada IncorporatedMême substance
XylacCanada · 2.5 MG · Tablet · Pendopharm Division of Pharmascience INCMême substance
XylacCanada · 25 MG · Tablet · Pendopharm Division of Pharmascience INCMême substance
Adasuve 9,1 MG Polvo Para Inhalacion (Unidosis)Espagne · 9,1 mg · polvo para inhalación (unidosis) · Ferrer Internacional S.A. · CommercialiséMême substance
Adasuve 9,1 MG Polvo Para Inhalacion (Unidosis)Espagne · 9,1 mg · polvo para inhalación (unidosis) · Ferrer Internacional S.A. · AutoriséMême substance
AdasuveUnion européenne · Ferrer Internacional S.A.Même substance
Adasuve

Conditionnement	Code	Statut
LOXAPINE SUCCINATE EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA017525-004	Discontinued
LOXAPINE SUCCINATE EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA017525-002	Discontinued
LOXAPINE SUCCINATE EQ 25MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA017525-003	Discontinued
LOXAPINE SUCCINATE EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA017525-001	Discontinued